156 results
Page 3 of 8
8-K
EX-99.1
65suh pnwxxo
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
celnavcw
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
hwqpbci
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
khsiotq5l8g99swfbtik
29 Jan 21
Index to Consolidated Financial Statements
4:08pm
8-K
EX-99.1
8co4l2jx
26 Jan 21
Other Events
4:14pm
DEFA14A
6q9u7zcvz7rjr
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
dta2t1th1zwa6 m3rr
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
ypmr43yowlbp2ke1n
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
d65br1jzxzyyj 5xq
21 Dec 20
Additional proxy soliciting materials
5:23pm
DEFA14A
zfehc l8l8vf
21 Dec 20
Additional proxy soliciting materials
5:21pm
DEFA14A
EX-99.1
gpo9tue
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
vlsmfp6wti0m
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
p85bzybn3dd621dj46qk
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
x3lt7k e2
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
cwjfn7gwkm3g0khhnc6
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
gqpisw
21 Sep 20
Other Events
7:14am
8-K
2va83ihr
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
8-K
EX-99.1
8okeg
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm